Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand
Scientific Reports · 09.01.2025 · 15 (1)
DOI: 10.1038/s41598-024-84392-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 09.01.2025. Verfasst von Daniel Ward und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine (LSHTM), Keppel Street, London, WC1E 7HT, UK. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Antibodies, Viral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
During the COVID-19 pandemic, heterologous vaccination strategies were employed to alleviate the strain on vaccine supplies. The Thailand Ministry of Health adopted these strategies using vector, inactivated, and mRNA vaccines. However, this approach has introduced challenges for SARS-CoV-2 sero-epidemiology studies. Our study analysed 647 samples from healthcare workers who received CoronaVac, ChAdOx1 nCoV-19, and BNT162b2 vaccines. The serological profile encompassed responses to various SARS-CoV-2 variants and vectors, measuring IgG, IgM, and IgA isotypes, alongside IgG avidity assays. The results demonstrated that heterologous CoronaVac/ChAdOx1 nCoV-19 schedules elicited significantly stronger antibody responses compared to homologous schedules (IgG: 1.2-fold, IgM: 10.9-fold, IgA: 3.1-fold increase). Additionally, a heterologous BNT162b2 boost at 4-weeks post-initial vaccination showed greater antibody levels than a ChAdOx1 nCoV-19 boost (IgG: 1.1-fold, IgM: slight decrease, IgA: 1.5-fold increase). Using a combination of three analytes, IgG against wild-type Spike trimer, nucleoprotein and Omicron receptor binding domains, enabled the clustering of responses within a statistical Gaussian mixture model that successfully discriminates between breakthrough infections and vaccination types (F-score = 0.82). The development of statistical models to predict breakthrough infections can improve serological surveillance. Overall, our study underscores the necessity for vaccine (re-)development and the creation of serological tools to monitor vaccine performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine (LSHTM), Keppel Street, London, WC1E 7HT, UK.
- Department of Medical Sciences, Medical Life Sciences Institute, Ministry of Public Health, 88/7 Tiwanon Road, Nonthaburi, 11000, Thailand.
- Department of Medical Sciences, Medical Life Sciences Institute, Ministry of Public Health, 88/7 Tiwanon Road, Nonthaburi, 11000, Thailand. surakameth.m@dmsc.mail.go.th.
- Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine (LSHTM), Keppel Street, London, WC1E 7HT, UK. taane.clark@lshtm.ac.uk.
- Faculty of Epidemiology and Population Health, LSHTM, London, UK. taane.clark@lshtm.ac.uk.
Zitieren
APA
Ward, D., Pattarapreeyakul, L., Pitaksalee, R., Thawong, N., Sawaengdee, W., Tuntigumthon, S., Patterson, C., Tetteh, K., Campino, S., Dhepakson, P., Mahasirimongkol, S., & Clark, T. G. (2025). Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-024-84392-2
Vancouver
Ward D, Pattarapreeyakul L, Pitaksalee R, Thawong N, Sawaengdee W, Tuntigumthon S, et al. Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand. Scientific Reports. 2025;15(1). doi:10.1038/s41598-024-84392-2
BibTeX
@article{Ward2025,
author = {Ward, Daniel and Pattarapreeyakul, Lapasrada and Pitaksalee, Rujiraporn and Thawong, Naphatcha and Sawaengdee, Waritta and Tuntigumthon, Suthida and Patterson, Catriona and Tetteh, Kevin and Campino, Susana and Dhepakson, Panadda and Mahasirimongkol, Surakameth and Clark, Taane G},
title = {Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand},
journal = {Scientific Reports},
year = {2025},
volume = {15},
number = {1},
doi = {10.1038/s41598-024-84392-2}
}
EUVIMED